Prenatal diagnosis and fetal pathology of I-cell disease (mucolipidosis type II).
Increased activity of several lysosomal hydrolases was demonstrated in amniotic fluid from a fifteenth week pregnancy in which the fetus had I-cell disease. Cultured cells from amniotic fluid had a decreased activity of the same enzymes. The diagnosis of I-cell disease was later confirmed by enzyme assays in cell cultures of fetal skin and by morphologic studies of several tissues from the aborted fetus. Electron microscopic studies of the fetal tissues and cultured fibroblasts had large numbers of typical inclusions of I-cell disease, thus substantiating the diagnosis and intrauterine manifestation of the disease. The results indicate that prenatal diagnosis of I-cell disease is possible with enzyme assays of amniotic fluid and in cultures of fetal cells from the fluid. Enzyme studies of amniotic fluid can provide a preliminary diagnosis within a few hours, but it is suggested that the definitive diagnosis should be based on assays in cultured cells from amniotic fluid.
D000118:Acetylglucosaminidase / Q000032:analysis; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000166:cytology / Q000201:enzymology*; D002478:Cells, Cultured; D005260:Female; D005347:Fibroblasts / Q000648:ultrastructure; D005696:Galactosidases / Q000032:analysis; D005959:Glucosidases / Q000032:analysis; D006026:Glycoside Hydrolases / Q000032:analysis*; D006596:Hexosaminidases / Q000032:analysis; D006801:Humans; D002479:Inclusion Bodies; D007668:Kidney / Q000648:ultrastructure; D008064:Lipidoses / Q000175:diagnosis* / Q000473:pathology; D008854:Microscopy, Electron; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D012867:Skin / Q000648:ultrastructure
D005696:Galactosidases; D005959:Glucosidases; D006026:Glycoside Hydrolases; D006596:Hexosaminidases; D000118:Acetylglucosaminidase